Published in


Moderna’s Lot Recall Is a Blot Despite Recent Good News

MRNA stock is down over 36% YTD and this news won’t help it rebound

Moderna (MRNA) reported today (April 8) the second recall of its Covid-19 vaccine due to contamination. Reuters reported that Moderna recalled 764,900 doses of its COVID-19 vaccine made by its contract manufacturer Rovi, based in Spain. That could hurt MRNA…



We curate and disseminate outstanding articles from diverse domains and disciplines to create fusion and synergy.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Mark Hake

CFA, MBA, and former hedge fund manager and investment research firm owner. Email me at if you have writing/research projects.